Acumen Pharmaceuticals, Inc.

ABOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jun 5, 2024 8-K
10-Q May 14, 2024 10-Q
8-K May 14, 2024 8-K
EFFECT Apr 24, 2024
CORRESP Apr 22, 2024
ARS Apr 22, 2024 ARS
DEFA14A Apr 22, 2024 DEFA14A
DEF 14A Apr 22, 2024 DEF 14A
UPLOAD Apr 2, 2024
S-3 Mar 27, 2024 S-3
S-8 Mar 27, 2024 S-8
10-K Mar 26, 2024 10-K
8-K Mar 26, 2024 8-K
8-K Mar 19, 2024 8-K
SC 13G/A Feb 14, 2024
SC 13G Feb 6, 2024
4 Feb 1, 2024 FORM 4
3 Feb 1, 2024 FORM 3
8-K Feb 1, 2024 8-K
SC 13G/A Jan 24, 2024 SC 13G/A
4 Jan 19, 2024 FORM 4
4 Jan 19, 2024 FORM 4
4 Jan 19, 2024 FORM 4
4 Jan 19, 2024 FORM 4
4 Jan 19, 2024 FORM 4
← Newer Page 8 of 15 · 365 filings Older →